Although PD-1 blockade increased the percentage of CD117− ILC2s, overall survival was correlated to a lower frequency of this subset in the periphery, potentially suggesting that there may be a requirement for the migration of these ILC2s into the tumor for a positive response [149]. This evidence concerns the gene PDCD1 and neoplasm.